Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity
Keywords: nor-BNI، nor-binaltorphimine; ATPM-ET, (-)-3-N-Ethylamino-thiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride; (-)U50488H, trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide; nor-BNI, Nor-binaltorphimine; β-FNA, β-funaltrexamine; CPP, conditioned place